Transcript
Page 1: Sonia Da Rochas / Novaptech, biotechnological development of aptamers

Biotechnological development of Aptamers

Dr. Sonia Da Rocha Gomes

Emilie Daguerre

Laetitia Evadé-Farrugia

Novaptech,

146 rue Léo Saignat, bat 3A, BP12

Bordeaux, France

[email protected]

+33.5.57.57.95.05

10th April 2014, Human Health Track, Barcelona

Page 2: Sonia Da Rochas / Novaptech, biotechnological development of aptamers

Novaptech, business unit

-Created in 2008,

-3 people, Bordeaux

-Dedicated to the biotechnological development of APTAMERS

-Managed by the association

-Connected to the academic lab Inserm U869, Dr. Toulmé ’s team > 15 years of expertise in

aptamer field (11th, Agrofood session)

- Two automated platforms of selection and aptamer production, unique in France

Aptamer production

- Identification - Optimization - Conjugation

Aptamer-based tools

in analytical, diagnostic

or therapeutic fields

Method development

-Implementation of new strategies

-Improvement of the automated platforms

OFFER :

Aptamer selection against your target and

characterization

Service contracts with academic labs and

companieS

30 projects

Page 3: Sonia Da Rochas / Novaptech, biotechnological development of aptamers

Your needs, looking for new molecular probe

DETECTION AND MONITORING (molecular imaging,

biosensors, sandwich assay)

PURIFICATION (affinity capture, sorting)

CHARACTERIZATION (target validation,

protein-binding RNA sites)

INHIBITION (drug delivery, drug discovery) REGULATION

(artificial riboswitch)

Aptamers, the right solution

Page 4: Sonia Da Rochas / Novaptech, biotechnological development of aptamers

Aptamer properties,

Structured oligonucleotides identified:

from randomly synthesized library

against a target

through combinatorial strategy (SELEX)

iterative rounds of selection / amplification

(Tuerk and Gold,1990; Ellington and Szostak, 1990)

High affinity and specificity

Rival antibodies

Chemical synthesis

Chemically modified and

conjugated to numerous pending

groups (fluorophore,

radioelements, biotin..)

Page 5: Sonia Da Rochas / Novaptech, biotechnological development of aptamers

Aptamer selection process,

146 rue Léo Saignat, bat 3A, BP12 Bordeaux, France

[email protected] +33.5.57.57.95.05

Phase 1

Phase 2

Automated platform for aptamer selection, unique in France (Inserm U869 lab)

Aptamer

Selection

Screening

(Affinity)

Cloning

Sequencing, Sequence analysis

Candidates production and

binding validation

Optimization

- Minimizing their size

- Improving nuclease resistance

- Conjugation: biotine, amine, fluorochrome..


Top Related